Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Epilepsy
Public ClinicalTrials.gov record NCT01339559. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label, Multicenter, Follow-up Study to Evaluate the Long-term Safety and Efficacy of Brivaracetam Used as Adjunctive Treatment in Subjects Aged 16 Years or Older With Epilepsy
Study identification
- NCT ID
- NCT01339559
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- UCB BIOSCIENCES, Inc.
- Industry
- Enrollment
- 767 participants
Conditions and interventions
Conditions
Interventions
- Brivaracetam Drug
Drug
Eligibility (public fields only)
- Age range
- 16 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 10, 2011
- Primary completion
- Apr 17, 2019
- Completion
- Apr 17, 2019
- Last update posted
- Aug 16, 2021
2011 – 2019
United States locations
- U.S. sites
- 49
- U.S. states
- 25
- U.S. cities
- 43
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 001 | Phoenix | Arizona | 85004 | — |
| 013 | Phoenix | Arizona | 85006 | — |
| 006 | Tucson | Arizona | 85718 | — |
| 775 | Little Rock | Arkansas | 72205 | — |
| 025 | San Francisco | California | 94115 | — |
| 060 | Aurora | Colorado | 80045 | — |
| 071 | Miami | Florida | 33176 | — |
| 027 | Orlando | Florida | 32819 | — |
| 064 | Port Charlotte | Florida | 33952 | — |
| 023 | Atlanta | Georgia | 30322 | — |
| 048 | Rome | Georgia | 30165 | — |
| 039 | Boise | Idaho | 83702 | — |
| 029 | Chicago | Illinois | 60612 | — |
| 005 | Peoria | Illinois | 61637 | — |
| 017 | Winfield | Illinois | 60190 | — |
| 020 | Ames | Iowa | 50010 | — |
| 069 | Iowa City | Iowa | 52242 | — |
| 780 | Lexington | Kentucky | 40536 | — |
| 008 | Bethesda | Maryland | 20817 | — |
| 068 | Waldorf | Maryland | 20603 | — |
| 009 | Golden Valley | Minnesota | 55422 | — |
| 032 | Lebanon | New Hampshire | 03756 | — |
| 042 | Hamilton | New Jersey | 08619 | — |
| 099 | New York | New York | 10011 | — |
| 022 | New York | New York | 10016 | — |
| 098 | Poughkeepsie | New York | 12601 | — |
| 010 | Asheville | North Carolina | 28806 | — |
| 003 | Durham | North Carolina | 27705 | — |
| 034 | Cleveland | Ohio | 44195 | — |
| 778 | Columbus | Ohio | 43210 | — |
| 070 | Columbus | Ohio | 43215 | — |
| 002 | Toledo | Ohio | 43614 | — |
| 043 | Oklahoma City | Oklahoma | 73112 | — |
| 091 | Oklahoma City | Oklahoma | 73112 | — |
| 054 | Tulsa | Oklahoma | 74136-83 | — |
| 015 | Philadelphia | Pennsylvania | 19107 | — |
| 028 | Charleston | South Carolina | 29425 | — |
| 021 | Port Royal | South Carolina | 29965 | — |
| 776 | Nashville | Tennessee | 37232-25 | — |
| 061 | Austin | Texas | 78758 | — |
| 011 | Dallas | Texas | 75251 | — |
| 777 | Dallas | Texas | 75251 | — |
| 035 | Dallas | Texas | 75390 | — |
| 049 | Houston | Texas | 77025 | — |
| 050 | Mansfield | Texas | 76063 | — |
| 036 | Charlottesville | Virginia | 22908 | — |
| 056 | Spokane | Washington | 99204 | — |
| 052 | Madison | Wisconsin | 53715 | — |
| 057 | Milwaukee | Wisconsin | 53215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 135 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01339559, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 16, 2021 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01339559 live on ClinicalTrials.gov.